Abstract
The study of sleep in nonmammalian organisms such as insects, birds, and reptiles has revealed many genetic and molecular clues in the understanding of human sleep disorders. Model organisms such as the fruit fly have contributed remarkable insights into our understanding of the mechanisms important to the expression of both normal and abnormal human sleep. Although the cellular and genetic bases for human sleep disorders are not completely understood at the present time, nonmammalian animal studies continue to provide important insights and clues in unraveling the mysteries of sleep. This chapter summarizes the relevant literature from phylogeny which has contributed to our understanding of the genetic, molecular, and environmental factors contributing to the expression of sleep in humans.
Access provided by CONRICYT-eBooks. Download chapter PDF
Similar content being viewed by others
Keywords
- Drosophila melanogaster
- Danio rerio
- Caenorhabditis elegans
- Genetics of sleep
- Unihemispheric sleep
- Sleep and mortality
- Human sleep disorders
- Model organisms
Sleep is a mysterious, intricate biological symphony which is composed and conducted by the genetics, anatomy, physiology, neurochemistry, environment, and psychology of living organisms. The phenomenon of sleep is not a uniquely human experience, and with many variations on a theme, it is ubiquitous throughout the animal kingdom. In order to understand why we sleep and why there are perturbations which result in sleep disorders, it is of importance to study sleep in many different living organisms, including those with a long phylogenetic history, which may shed light on the origins of sleep. However, one might reasonably ask how can the study of sleep in diverse creatures such as insects, reptiles, birds, and dolphins—organisms so unlike ourselves—contribute to our knowledge about human sleep? At first glance the immediate answer would appear to be “not much.” However, to entertain the possibility that the study of animal sleep is inconsequential or even irrelevant in understanding human sleep and its disorders would be shortsighted. The identification and study of model organisms such as the fruit fly (Drosophila melanogaster), for example, have produced a dramatic explosion in our molecular and genetic knowledge about the mechanisms controlling the expression of sleep. These findings reverberate with new insights across the entire spectrum of sleep disorders medicine. Although the exact functions and purposes of sleep still remain unknown, many pieces of the sleep puzzle derived from phylogenetic studies have laid the foundation for unraveling these mysteries.
Most animal sleep studies have been performed in familiar mammals, and a recent review [1] underlines the fact that primarily mice, rats, cats, and dogs have been used experimentally to construct animal models of human sleep disorders. However, the literature is rich with studies of unusual mammalian and nonmammalian species which, although displaying remarkable variations in environment, evolutionary history, behavior, life span, anatomy, and physiology, exhibit the behavioral characteristics of sleep and provide clues to the origins of sleep. At least from a behavioral standpoint, sleep appears to be a universally conserved phenomenon, and as we shall see, genetic and molecular aspects of sleep have also been conserved. Insects, fish, amphibians, reptiles, and invertebrates as well as mammals including egg laying monotremes (platypus and echidna), marine-dwelling cetaceans (whales, dolphins, porpoises) and pinnipeds (seals), marsupials (kangaroo, possum), and placental mammals all display behavioral sleep. Documentation of distinctive electrophysiology, which can be different from that of mammals, may also accompany behavioral sleep in nonmammals. By studying living organisms with a long history in the fossil record, clues to the role of sleep in species survival as well to the function of sleep might be obtained. There are several recent detailed reviews on behavioral and electrophysiological characteristics of mammalian and nonmammalian sleep [2–6]. Here, we will not recapitulate these details, but rather draw upon relevant studies from the animal literature to explore how clues from phylogenetic studies have contributed to the understanding of human sleep and human sleep disorders.
The Definition of Sleep
The first task in understanding sleep mechanisms is to define sleep. There are two different approaches to this definition, behavioral and electrophysiological. The behavioral definition of sleep is well established, and behavioral criteria have been used to identify sleep in diverse insects, invertebrates, mammalian, and nonmammalian organisms. These criteria include (1) a species specific posture; (2) behavioral quiescence; (3) increased arousal thresholds; (4) state reversibility to distinguish sleep from coma or torpor; and (5) a homeostatic response to sleep deprivation, i.e., an increase in sleep amount following sleep deprivation. In mammals, there are distinctive electrophysiological events which accompany behavioral sleep and which distinguish sleep from wakefulness. During nonrapid eye movement (NREM) sleep, the EEG is characterized by high amplitude slow waves as well as by other distinctive wave forms such as sleep spindles and K complexes. In humans, NREM sleep has been subdivided into three or four separate sleep stages with specific EEG waveform criteria detailed for each stage [7, 8]. Rapid eye movement (REM) sleep alternates in a cyclical fashion with NREM sleep. REM sleep is characterized by a low amplitude EEG similar to that of waking, skeletal muscle atonia, and rapid eye movements. REM sleep is a period of intense physiological activity in a sleeping organism and other distinctive events during REM sleep include vivid dreaming in humans, increased single neuron firing in the brain, increases in brain temperature, and penile erections. REM sleep is also referred to as paradoxical sleep (PS) recognizing the incongruity of this active physiology in a sleeping organism.
Since there is a close correspondence between the distinctive electrophysiological markers of mammalian sleep and behavior, electrophysiology is generally a more efficient means, rather than continuous visual observation of behavior, in defining mammalian sleep. However, as we shall see, although the behavioral criteria for sleep may be met, the electrophysiological expression of sleep is often different in nonmammalian species.
In comparison with mammals, there are relatively few electrophysiological studies which have been performed during behavioral sleep in nonmammalian organisms. Furthermore, there is controversy as to whether the “true” indicators of electrophysiological sleep are present since nonmammalian electrophysiology is quite different from that of mammals. The high amplitude slow waves defining mammalian NREM sleep have not been reliably observed during nonmammalian behavioral sleep with the exception of birds [9]. Similarly, REM sleep has not been rigorously documented in nonmammals, again with the exception of brief bouts of avian REM sleep usually lasting less than 10 s. In mammals, the thick neocortical layer responsible for generating slow wave activity, is absent in nonmammals, making it unlikely that slow waves can be generated without this anatomical substrate. There are some scattered observational reports of REM sleep in nonmammals, but most studies have not presented rigorous or convincing evidence for REM sleep.
There is, however, a variety of other electrophysiological correlates associated with behavioral sleep in invertebrates and nonmammalian vertebrates. A sampling reveals a decline in local field potentials during behavioral sleep in fruit flies [10, 11], spindle-like activity during quiescence in the frog [12], isolated spikes and spike trains during behavioral quiescence in the octopus [13], spikes during behavioral wakefulness and waves of 15–20 Hz during behavioral sleep in the crayfish [14], and high amplitude spikes during behavioral sleep which disappear with behavioral waking in turtles, tortoises, lizards, and caiman [15–18].
These findings, which are dissimilar to the electrophysiology of mammalian sleep, have prompted debate as to whether the sleep of nonmammalian organisms is the same state as mammalian sleep and whether it is logical or scientifically reasonable to impose the mammalian criteria for sleep on nonmammalian species [19–21]. Other electrophysiological findings which further complicate the picture include reports of high amplitude slow waves characteristic of mammalian NREM sleep occurring during behavioral sleep in young caimans [22], REM sleep in lizards [23], high amplitude slow waves during waking in lizards [24], and high amplitude spikes during reptilian behavioral sleep which appear to be analogous to ventral hippocampus spikes recorded during NREM sleep in mammals [25]. Libourel and Herrel [4] have recently suggested that explanations for these varied findings in reptiles may be the result of differences between natural or seminatural recording conditions and laboratory conditions, differences in habituation to the recording environment, differences in electrophysiological recording techniques, methodological differences in evaluating arousal responses, and differences in electrode placements since no stereotaxic atlases of reptilian brains are available to ensure consistency of electrode placement. This debate surrounding sleep in reptiles is central to the question of whether nonmammalian organisms sleep if they do not exhibit mammalian electrophysiology. Rather than attempt to resolve this issue, examples from phylogenetic sleep studies will be used to evaluate the contribution of phylogeny to human sleep.
Model Organisms in the Study of Sleep
The revolution in our current knowledge about the neurochemical, molecular, and genetic bases for sleep has been propelled forward at an extraordinary rate by the introduction of model organisms, primarily the fruit fly (Drosophila melanogaster), and round wormas (Caenorhabditis elegans) as well as the zebrafish (Danio rerio) (Figs. 9.1, 9.2, 9.3). Compared to mammals, there are a number of features which make these organisms both practical and scientifically desirable for study. There is economic and logistical ease in maintaining large colonies, and a short life span as well as short reproductive cycles allow for the rapid evaluation of experimental manipulations. Increased statistical power can be achieved as the result of a large number of available subjects, and there is the potential for rapid replication of results in genetically identical organisms under similar conditions. Furthermore, the presence of drosophila appendages such as wings and legs allow for observations of complex behaviors. The most significant scientific advantage is the relatively small number of neurons (approximately 100,000) in the adult drosophila brain as compared to the staggeringly large number of neurons (approximately 86 billion) in the adult human brain [26, 27]. The drosophila genome has been mapped with shared homologues identified in humans [28–31]. In addition, the neurotransmitters which have been demonstrated to play a role in the control of human sleep, including serotonin, dopamine, acetylcholine, GABA, and epinephrine (the equivalent of octopamine in drosophila), and in the case of zebrafish, orexin, are present [32, 33].
A model organism is a model only if, despite strong genetic similarities to humans, there is evidence that behavior meets the criteria for sleep. Drosophila quiescence does fulfill the criteria established for behavioral sleep [34, 35]. Behavioral quiescence, a stereotypic posture, elevated arousal thresholds, state reversibility with stimulation, and a homeostatic response to deprivation of rest, i.e., rest increased following the period of rest deprivation are present. This homeostatic response to deprivation is independent of at least one central clock gene, indicating that the homeostatic response is not simply a circadian response rather than a response to rest deprivation. Additional evidence for the similarity between drosophila quiescence and human sleep includes a similar response to drugs including caffeine, modafinil, and methamphetamine [36–38]. Antihistamines increase quiescent periods in drosophila similar to drowsiness in humans [35]. Finally, there are age-related changes in sleep similar to the changes in sleep amounts across the human life span [35, 39].
Drosophila is the organism which has arguably received the most attention as a model system for the genetic and molecular study of sleep. However, zebrafish (D. rerio) also offer similar biological and behavioral properties with respect to sleep for consideration as a model organism [40, 41]. Another proposed model organism is the round worm (C. elegans). During lethargus, a quiescent behavioral state which occurs after each of four molts, the behavioral criteria for sleep, including a homeostatic response to rest deprivation and elevated arousal thresholds, are present [42, 43]. There is genetic and molecular conservation between drosophila and C. elegans [44, 45]. A recent study also provides evidence that quiescence during molts in another worm, the tobacco hornworm (Manduca sexta), meets the behavioral criteria for sleep [46]. Thus, these model organisms with their practical and experimental advantages may have the potential to observe, and perhaps unlock, the underlying mechanisms controlling the expression of sleep.
Optimal Sleep and Mortality
The ill effects of insufficient sleep may be witnessed on some of the principal organic functions, but it is the brain and nervous system that suffer chiefly in the first instance. The consequences of a too protracted vigil are too well known to be mistaken, and many a person is suffering, unconscious of the cause, from the habit of irregular and insufficient sleep.
William A. Hammond, 1866 [47].
The consequences of insufficient sleep have long been a subject of debate and discussion. Still today, some of the most common questions asked of sleep clinicians revolve around sleep quality and sleep amounts: How many hours of sleep per night are necessary for good health, is a lack of sleep harmful, and will inadequate amounts of sleep or poor quality sleep affect longevity? As we shall see, there are data to suggest that too little or too much sleep may impact health and life span in humans. For example, persistent, but not intermittent, self-reported insomnia is associated with an increased risk of all-cause mortality over a 20-year follow-up period, suggesting that decreased sleep amounts negatively impact life span [48]. In contrast, prolonged sleep amounts have been associated with an increased risk of fatal and nonfatal stroke [49], conversely suggesting that increased sleep amounts negatively impact health. Although studies of sleep in nonhuman organisms reveal significant variations in sleep amounts, there are no data available which shed light on the impact of these variations in promoting species survival and longevity. As we shall see, however, there are examples of “natural” sleeplessness in the animal world, and most importantly the genetic manipulation of model organisms has advanced our knowledge about the mechanisms controlling sleeplessness.
One approach to addressing the question of whether there are optimum amounts of sleep associated with a long life span would be to examine the relationship between sleep amounts and mortality in large populations. A systematic relationship between human sleep and mortality was first described over 30 years ago [50], and since that time a body of epidemiological literature has accumulated which suggests fairly consistently that short and, somewhat inconsistently, that long sleep amounts are associated with increased mortality as well as with diseases such as obesity, diabetes, hypertension, and cardiovascular disease [51–55]. Typically, the best survival curves are associated with about 7 h of sleep per night. Shorter sleep times are variably defined in these studies as 4–6 h per night and long sleep times as more than 8–9 h per night, raising the question of whether the common recommendation of a minimum of 8 h of sleep per night is appropriate [56]. Of note is that in virtually all epidemiological studies, sleep duration was assessed by subjective estimates and not overnight sleep studies utilizing polysomnography, suggesting the possibility of subjective over- and underestimates of sleep duration which could bias results. Also, it cannot be determined in these epidemiological studies whether short and long sleep durations are the direct cause of increased mortality or whether short and long sleep durations are the product of an underlying intervening condition which in turn is responsible for these associations with mortality.
The most extensive and rigorous review of the literature addressing the question of optimal sleep time was recently performed by a panel of sleep experts assembled by the American Academy of Sleep Medicine and the Sleep Research Society [57]. The consensus of the panel was that less than 6 h of sleep is inadequate to support optimal health, but no consensus could be reached about the effects of 9 h or more on optimal health. The final consensus was that 7 h was the minimum amount of daily sleep necessary to support optimal health. However, no consensus could be reached about an upper maximum threshold of sleep for optimal health. This is not surprising. A careful review of the epidemiological studies supporting a relationship between sleep duration and mortality raises the issue of, for example, how variable methodologies for determining total sleep time may weaken the conclusions which can be drawn from the U-shaped curve characteristic of the relationship between sleep duration and mortality [58]. Also of interest in these considerations of mortality and sleep duration is the demonstration of a dose–response relationship between hypnotic sleep medications typically used to treat short sleep and an increased mortality risk as well as an increased cancer risk for the most frequent users of hypnotics [59]. These findings suggest that intervening variables, inconsistently assessed in epidemiological studies, may contribute substantially to the association between sleep duration and mortality.
Human epidemiological studies, although inviting speculation about the predictive value of sleep amounts in determining life span, do not reveal the biological mechanisms responsible for this relationship. There are age-related changes in drosophila sleep similar to the sleep fragmentation and decreased sleep amounts observed in aging humans, suggesting that drosophila may shed light on the mechanisms mediating sleep and longevity in humans [39]. Several genetically engineered drosophila mutants, including Minisleep (mns), Hyperkinetic (Hk), Sleepless (sss), and Insomniac (inc), have been developed which have markedly reduced sleep amounts in comparison with wild-type flies [60–62]. Life span in these short sleeping flies is reduced, suggesting that sleep duration has a direct relationship to longevity. Of note is that waking behavior was not impaired in mutant strains. These mutations are mediated by Shaker, a gene which encodes for the voltage dependent potassium channel. Another short sleeping mutant, fumin (fmn), which has a mutation in the dopamine transporter gene (DAT), does not show a reduced life span nor do these flies exhibit a homeostatic response to sleep deprivation [63]. There is substantial evidence from a number of studies to indicate that dopaminergic systems have a major role in the expression of arousal and sleep [36, 64]. Mutations of the amnesiac (amn) gene, which has a role in the adenylate cyclase/cAMP signaling pathway, are associated with fragmented sleep and, similar to fmn, are not associated with a rebound in quiescence following deprivation [65]. Of note is that a high-calorie diet in fmn mutants results in further reductions in sleep amounts and reduced longevity, suggesting that accelerated aging and shortened sleep are impacted by increased caloric intake [66]. Also time-restricted feeding with food access limited to 12 h per day in wild-type flies, although not changing caloric intake, is associated with improvements in sleep and ameliorates an age-related cardiac decline [67]. These studies indicate that there are a number of different factors which affect the expression of sleep. Also of interest are mutations in genes which would not seem to play a role in sleep expression such as the fragile X mental retardation gene (Fmr1). Overexpression of drosophila Fmr1 results in shortened sleep, whereas the loss of Fmr1 is associated with significantly longer sleep amounts as compared to control flies. In neither mutant was there a homeostatic response to sleep deprivation, and of particular interest relevant to the human epidemiological studies is that life span is reduced in both the short and long sleeping Fmr1 mutants [68]. Finally, it is most likely that there is not a single dedicated “sleep gene,” but that other genes more broadly controlling cellular and neuronal functions also control the expression of sleep. An example is the demonstration that decreasing cyclin A, a protein which regulates the progression of cells through the cell cycle, results in decreased total sleep and a decrease in the homeostatic response to sleep deprivation [69]. More recently, a sleep regulating protein redeye (rye) which interacts with sss has been identified in short sleeping mutants and after sleep deprivation in wild-type drosophila [70].
The cellular mechanisms controlling sleep in humans are virtually unknown. The complaint of insomnia, difficulty falling and staying asleep typically with resulting daytime fatigue, affects approximately 30 % of the population in varying degrees of severity [71]. Not only physiological factors, but the contribution of psychological factors to this disorder, make it a daunting task to untangle the mechanisms which are involved in the expression of human sleeplessness. There are two disorders characterized by shortened sleep which have been identified in this category of sleep difficulties and which have a known genetic basis. The first is advanced sleep phase syndrome in which affected family members have a mutation of the hPER2 clock gene involved in controlling the timing of sleep. Although the sleep cycle is regular in affected family members, there is a four hour advance of sleep, temperature, and melatonin rhythms in affected as compared to unaffected family members [72]. A second disorder of sleeplessness with a known genetic basis is fatal familial insomnia. This disorder is a rare, inherited, progressive neurodegenerative disease in which there is a progressive inability to sleep eventually culminating in total sleeplessness and death [73]. Autopsy findings reveal selective bilateral neuronal loss and reactive gliosis of the anterior and dorsomedial thalamic nuclei with an accumulation of prion protein. In affected individuals, there is a single mutation on the prion protein gene PRNP at position 178 combined with a mutation at position 129 [74]. Although these are two very specific instances of sleep difficulty, there is, however, evidence to suggest that short sleepers do carry a gene with a specific DEC2 (also known as BhLHE41) mutation. This mutation was identified in a family with two individuals who had lifelong short sleep averaging 6.25 h per day as compared to noncarrier family members who averaged 8.06 h per day [75]. Subsequent work has identified other mutations of BHLHE41 associated with decreased total sleep time and with fewer average lapses in performance on a psychomotor vigilance task, suggesting resistance to the effects of sleep deprivation [76].
Despite this large body of literature which suggests that sleep and longevity are related, there continues to be no clear answer to the question of whether there is an optimal amount of sleep which can promote maximum longevity in humans. Additionally, understanding the genetic and cellular mechanisms responsible for human sleeplessness is clearly in its infancy. There are, of course, no formulas to translate the equivalency of drosophila sleep minutes which can be manipulated by these mechanisms into human sleep hours. As previously noted, at least some of the ambiguity in human studies may be related to subtle differences in survey questioning about sleep amounts which result in subjective under- or overestimation of sleep time [58].
There are also variables identified from drosophila studies which may interact with genetics to potentially affect sleep with respect to longevity including social enrichment or isolation, environmental conditions, diet, methods of evaluating quiescence, and climates and altitudes [77–82]. There is also recent evidence that variations in population density during normal drosophila larval development affect sleep duration in adults, but not in amn mutants, suggesting lifelong cellular changes in sleep controlling mechanisms dating from infancy as the result of environmental exposures [83]. Although not as intensively studied as drosophila, other mammals and nonmammals also demonstrate that environment and social experience may affect the expression of sleep. For instance, sleep in honey bees is increased by exposure to the bee colony environment in comparison with isolated bees [84]. Electrophysiological recordings of unrestrained sloths in the rain forest reveal that total sleep time is substantially less than under laboratory conditions [85]. The threat of predation and social status may also play a significant role in determining sleep amounts in mammals [86–88]. In reptiles, young caimans recorded in a colony exhibited differing electrophysiology from caiman recorded in isolation, suggesting that these differences in environment and socialization may have affected the expression of sleep [17, 22].
The most striking example of the evolutionary effects of habitat upon sleeplessness is illustrated by studies in the Mexican cavefish (Astyanax mexicanus) [89, 90]. Surface- and cave-dwelling populations of these fish differ remarkably in daily sleep amounts with surface fish averaging over 800 min and three different cave-dwelling populations averaging 110–250 min per day. Blockade of B-adrenergic receptors with propranolol produced dose-dependent increases in cave fish sleep without any effect at any dose on sleep of surface-dwelling fish. Adrenergic antagonists did not affect sleep in surface dwellers, but cavefish sleep increased significantly in response to the B1 antagonist atenolol. The number of catecholamine neurons is conserved in cavefish as opposed to surface-dwelling fish, suggesting that an increase in the adrenergic arousal system in cavefish as compared to surface dwellers has occurred during evolution. Other recent fish studies have examined circadian rhythmicity in aging killifish (Nothobranchius) as well as the induction of quiescence by melatonin in the three spot wrasse (Halichoeres trimaculatus) [91, 92].
In summary, much of the appeal of the findings from human epidemiological studies resides in the simplicity of the U-shaped curve which suggests that the relationship between longevity and sleep is straightforward. Both short sleep and long sleep are associated with increased mortality. However, as we have seen from the animal literature, these data are fraught with many potentially uncontrolled and confounding genetic, environmental, and ecological factors which have the potential to alter this relationship. An unambiguous answer to the question of how much sleep and under what conditions are necessary for optimal longevity remains unanswered.
Pharmacological Development
A significant advantage of utilizing model organisms to explore the molecular basis of sleep lies in their well-studied genome which is amenable to precise manipulation. Another potentially productive area in which these model organisms may be of substantial benefit is in the area of developing new and focused pharmacological treatments for human diseases, including sleep disorders [30]. For example, approximately 70 % of human genes have at least one zebrafish orthologue, and as a result, zebrafish have been extensively used to develop human disease models [28, 93]. The correspondences between the human genome and the genomes of model systems suggest that model organisms could be instrumental in developing in vivo drug treatments at a molecular level for modifying or treating human sleep disorders. Zebrafish are sensitive to major classes of drugs including anxiolytics, hypnotics, and stimulant among others which could potentially be used to treat disordered sleep [33, 40]. In addition, the cost of screening pharmacologically active compounds is substantially less expensive in an organism such as the zebrafish so that an increased number of compounds can be economically evaluated. New effects and mechanisms of drug action on waking and quiescence produced by similar major neurotransmitter pathways in both zebrafish and mammals, and identification of poorly understood compounds can be rapidly assessed.
Cross-translational studies between model organisms and humans also open new avenues for the discovery of waking and sleep biomarkers which may have practical application. One example is the discovery of salivary amylase as a biomarker for sleepiness and sleep drive in both drosophila and humans utilizing cross-translational studies [38, 94]. The potential applications of such a “sleepiness marker” are far reaching. For example, multiple sleep latency testing (MSLT), a series of daytime nap tests spaced throughout the day according to a standard protocol, is currently the standard electrophysiological assessment tool for objectively evaluating a patient’s subjective complaint of sleepiness. The maintenance of wakefulness test (MWT) is used in a similar protocol to evaluate daytime alertness [95]. With further elaboration of the salivary amylase findings, convenient, rapid, cost-effective alternatives to the MSLT and MWT could potentially be developed for objective assessment of sleepiness and alertness in settings where polysomnography is unavailable. Another practical application of these findings may be the assessment of drowsy drivers similar to breathalyzer assessments of alcohol consumption or the assessment of persons such as air traffic controllers, bus drivers, or train conductors whose occupations require a high degree of alertness to ensure public safety.
The utilization of model organisms for development of effective pharmacological treatments and sleep-related biomarkers is still in development. However, as knowledge about sleep mechanisms continues on a rapid, steep trajectory, it is not unreasonable to anticipate that the practical application of this knowledge will also follow.
Sleep Disorders
Narcolepsy
The mechanisms underlying the expression of narcolepsy were virtually completely unknown until the serendipitous discovery by Dr. William Dement of a dog with what appeared to be cataplectic attacks similar to the cataplectic attacks demonstrated by human narcoleptic subjects [96]. Since that time, understanding the etiology of narcolepsy has arguably been primarily the result of discoveries in animal research [97, 98]. The cardinal symptoms of narcolepsy include excessive daytime sleepiness, hypnagogic hallucinations, sleep paralysis, and cataplexy, a sudden loss of muscle tone with strong emotions. Electrophysiologically, narcolepsy is diagnosed by the rapid onset of REM sleep, typically with a latency of less than 15 min as compared to the 60- to approximately 90-min latency to the onset of REM sleep in normal subjects. Narcolepsy, in conjunction with a history of clinical symptoms, is diagnosed by the rapid onset of REM sleep during a protocol of daytime nap testing [95]. Based on epidemiological studies in several countries, the prevalence of narcolepsy has been estimated at between 25 and 50 per 100,000 persons [99]. Of all the sleep disorders, the genetics, neuropharmacology, and molecular mechanisms of narcolepsy appear to be the best understood [100]. The discovery of orexin (hypocretin) deficiency resulting from the loss of orexigenic neurons in narcoleptic dogs, mice, and humans and the close association of the human leukocyte antigen DQB1*0602 and DQA1*0102 in almost all narcoleptics has led to the conclusion that narcolepsy is an autoimmune disease [101]. However, the mechanisms by which orexin is depleted are unknown. Potential environmental triggers for the development of narcolepsy which have been identified include upper airway infections and the H1N1 flu vaccine in genetically susceptible individuals [102, 103].
Gene therapy clinical trials are now being performed for a variety of human diseases including cancer, cardiovascular disease, Parkinson’s disease, and cystic fibrosis [104]. Hypothalamic gene replacement therapy in orexin-deficient mice improves sleep quality and the timing of REM sleep, but does not improve cataplexy [105]. Conversely, gene transfer into the zona incerta in orexin-deficient mice improves cataplexy, but not sleep fragmentation [106]. There are no data on gene replacement in narcoleptic humans, but the findings in mice suggest that this approach may be a promising one. As the result of this research in narcolepsy, a new sleeping medication, suvorexant, has been developed as a treatment for insomnia. Suvorexant is a dual orexin 1 and orexin 2 receptor antagonist which dose dependently enhances sleep in humans [107, 108]. Suvorexant was approved for human use by the Food and Drug Administration in August, 2014. Of interest is a detailed account of suvorexant’s approval process which appeared in the popular press [109].
A major stumbling block in the use of model organisms to study narcolepsy is the absence of REM sleep. Birds are the only nonmammalian organism to display convincingly behavioral and electrophysiological signs of REM, but avian REM sleep bouts are brief, lasting only a few seconds. Could it be possible that REM sleep is present in drosophila or zebrafish and that it has simply been missed? This seems unlikely particularly in light of a recent detailed video analysis of zebrafish eye movements and respiration during sleep which did not uncover any credible evidence for the presence of REM [110]. Additionally, the limited behavioral repertoire of model organisms precludes their usefulness in evaluating, for example, cataplexy or sleep paralysis which are major signs of narcolepsy. The drosophila brain does not contain orexin. However, zebrafish have a distribution of orexin expressed in the brain in a fashion similar to that of mammals [111]. Overexpression of orexin in zebrafish results in elevated motor activity, decreases in arousal thresholds, and shortened, disturbed sleep in the dark [111, 112]. During the course of evaluating zebrafish hypocretin receptor mutants, Yokogawa et al. [112] made several interesting observations with respect to sleep. Normal adult zebrafish maintained under constant light conditions have an almost complete suppression of sleep. A homeostatic rebound response to this sleep deprivation was not observed, and a progressive return to sleep occurred over the course of one to two weeks. Following sleep deprivation in response to electrical stimulation, there was no homeostatic response when animals were released into light, but a homeostatic rebound occurred with release into darkness. Additionally, exposure to light during the last 6 h of the biological night produced a marked suppression of sleep without a homeostatic rebound with release into darkness.
Although the orexigenic substrate of the zebrafish brain parallels that of the mammalian brain, the zebrafish is not a particularly enlightening model organism to elaborate upon mechanisms controlling narcolepsy. None of the model organisms studied to date would appear to serve as a model for narcolepsy. Furthermore, the unusual response of zebrafish sleep to light with sleep suppression and to the absence of a homeostatic response following sleep deprivation suggests that there are components of zebrafish sleep which should not be considered as a model substrate for sleep disorders.
Sleep Apnea
The cardinal symptoms of obstructive sleep apnea (OSA) are well known and unmistakable in their presentation: loud snoring and pauses in respiration terminated by explosive snores, breath holding episodes witnessed by a bed partner, and excessive daytime sleepiness resulting from the arousals terminating often hundreds of respiratory pauses during sleep. Severe OSA is a risk factor for arterial hypertension, heart failure, stroke, pulmonary hypertension, and maternal morbidity [113, 114]. A familial component has been described in several studies [115–117]. There are two reports of a naturally occurring model of sleep apnea in the English bulldog which has a crowded upper airway anatomy similar to sleep apnea patients [118] and in obese miniature pigs [119]. Nonmammalian species have not been observed to have sleep apnea, and model organisms have not been developed for experimental evaluation of this disorder.
The experimental research on sleep apnea has been focused on the induction of sleep apnea in dogs, rats, and mice by artificially occluding the airway and exposure to repetitive hypoxemia [120–123]. The cardiovascular and neurochemical consequences of sleep apnea have been described in these experimental models, but the genetic and cellular components of sleep apnea are not well understood. OSA is a complex disease process with multiple interactive factors including age, weight, gender, arterial and pulmonary hypertension, cardiovascular disease, and metabolic disorders. It is almost certainly the case that there are multiple cellular and genetic components contributing to the expression of OSA. A gene encoding the allele APOEe4 which is essential for cholesterol metabolism and transport has been associated with OSA in adults and children. However, a meta-analysis of studies reporting an association between APOE and sleep apnea concluded that the association is weak [124]. Another meta-analysis of OSA genetic association studies revealed that TNFA rs1800629, which may also be associated with heart disease and heart failure as well as chronic obstructive pulmonary disease, was significantly associated with OSA [125]. These authors concluded that studies examining OSA genetics did not typically provide robust evidence. Thus, the complexity of OSA presents significant challenges in understanding the genetics of this order, and at least at the present time, a model organism with a well-known genome combined with the symptoms of OSA does not appear to be on the horizon.
Restless Legs Syndrome (RLS)
Clinical symptoms of RLS include restless, creeping, crawling, uncomfortable sensations in the legs during sedentary activities with a worsening of these sensations beginning in the evening. They are accompanied by an irresistible urge to move the legs for temporary relief. Typically, there is a worsening of the sensations at sleep onset which results in substantial difficulty falling asleep. Key factors in the expression of RLS are iron deficiency and the involvement of the dopaminergic system in regulating iron metabolism, although the mechanism of this relationship is not clearly understood. Currently, dopamine agonists, such as ropinirole and pramipexole, which enhance brain dopamine, are the treatments of choice for RLS [126]. Prevalence, depending upon the complexity of survey questions, ranges between 9.4 and 15 % querying RLS as a single symptom. This range changes somewhat to 3.9–14.3 % utilizing the criteria of the International Restless Legs Syndrome Study Group [127, 128]. Inclusion of stricter diagnostic criteria such as the frequency and severity of symptoms results in decreased estimates of prevalence.
Genome-wide association studies (GWAS) have opened a new window onto the genetic underpinnings of human RLS. GWAS studies in both European and US populations have identified genomic loci which are associated with restless legs syndrome including MEIS1, BTBD9, and MAP2K5/LBXCOR1 on chromosomes 2p, 6p, and 15q [129–131]. Animal models have been proposed for the study of restless legs syndrome. Mice and rats with lesions of the A-ll dopaminergic nucleus which projects to the spinal cord have demonstrated an increase in locomotor activity [132, 133]. Spontaneously hypertensive rats exhibit increased motor activity, suggesting a possible model for the study of RLS [134]. One study in C. elegans demonstrated that the MEIS1 worm orthologue increased ferritin expression and human cells cultured in iron-deficient conditions revealed decreased MEIS1 expression, lending further support to the role of these genes in iron metabolism [135].
Animal studies are typically the catalyst for human research. However, the discovery of these potential RLS loci via human GWAS provided a reverse “human to animal” stimulus for the development of a drosophila RLS model [136]. As described above, the diagnosis of RLS in humans is accompanied by reports of an irresistible urge to move the legs for relief of discomfort. Of course, these sensations cannot be communicated by drosophila, but movement can be operationally used to infer the presence of RLS. Genetic alteration of the fly homologue dBTBD9 which corresponds to human BTBD9 resulted in fragmented sleep characterized by a decrease in the duration of sleep bouts and an increase in the number of sleep bouts and waking after sleep onset, suggesting the sleep fragmentation of RLS patients. However, sleep duration in flies per 24-h period was not different between mutants and controls. Although flight and negative geotaxis were normal in mutants, when confined to a restricted space flies were hyperlocomotive, reminiscent of the movements experienced by RLS patients during the forced immobility test (FIT) [137]. Uninterrupted bouts of walking were also longer in mutants. Comparing dopamine levels in mutants and controls, mutants revealed a 50 % reduction in dopamine, suggesting a relationship between alterations between BTBD9 and maintenance of normal dopamine levels. Also of note is that treatment with pramipexole, a dopamine agonist, restored sleep consolidation in mutants to control levels, again suggesting a significant role for dopamine in the expression of RLS. dBTBD9 is also implicated in the regulation of iron metabolism and ferritin homeostasis.
These genetic explorations into the expression of RLS in a model system provide evidence of the complex relationship between specific genes and the role of dopamine in regulating ferritin levels. Ideally, with further studies more effective treatments for RLS will be discovered.
Unusual Sleep Disorders
There is a group of unusual sleep disorders, the parasomnias, in which the distinction between waking and sleep becomes blurred and waking behavior appears to intrude into sleep. Included in this group of disorders are confusional arousals, REM behavior disorder (RBD), sleep walking, and sleep-related eating disorders [138]. Complex vigorous motor activity which can become violent in the case of RBD and loud vocalizations may accompany these disorders. Not a great deal is known about the prevalence of parasomnias, but sleep walking, for example, is relatively common with a lifetime prevalence estimated at 29.2 % [139]. RBD is rarer with a prevalence of 2.01 % and subclinical RBD estimated at 4.95 % in a Korean elderly population [140]. Due to the complexity of behavior in parasomnias, no animal models have been developed to study these disorders, and not surprisingly no naturally occurring animal models of parasomnias have been identified. However, early studies in cats revealed “dream enacting” behavior following pontine tegmental brainstem lesions, reminiscent of the vocalizations and motor movements in RBD [141, 142].
Can sleep and wakefulness be present in the same brain at the same time? This possibility seems counterintuitive to our normal experience since we typically dichotomize states of alertness as being either waking or sleep and the transition between them as drowsiness, often euphemistically described as being half awake or half asleep. The parasomnias suggest that the comingling of sleep and waking in the same neural substrate is possible, and insights from animal studies are of benefit in shedding light on this issue.
There are a number of examples in the animal literature in which “nonquiescent” or literally “motorically active” sleep is present, suggesting that sleep can be compatible with behavior typically present during waking. For example, nocturnal “sleep swimming” fish inhabiting coral reefs in the Red Sea vigorously move the dorsal, pectoral, and caudal fins in fixed body positions at a frequency of strokes approximately twice the rate with daytime swimming outside the coral reef [143]. This behavior may function to aerate the reef and assure healthy corals. Captive dolphin and killer whale neonates and their mothers remain continuously active and do not exhibit signs of behavioral sleep for several months postpartum with gradually increasing periods of behavioral quiescence which eventually return to normal amounts, but do not exceed normal amounts, of behavioral sleep [144, 145]. Dolphins are able to maintain continuous vigilance with accurate echolocation for a testing period of up to 15 days [146]. In the laboratory birds demonstrate marked decreases in EEG defined sleep during the migration season, and data from freely moving swifts equipped with data loggers during a 200-day nonstop flight suggest that sleep occurs during periods of decreased activity during flight [147–149].
There is the possibility that these animals are unique and simply do not sleep. However, this would be contrary to findings from virtually all other living organisms. Alternatively, a variant of sleep may be present which coexists with waking and which allows for sustained vigilance in the presence of physiological sleep. In fact, there is a unique form of sleep, unihemispheric sleep, a state in which one hemisphere of the brain exhibits waking EEG activity simultaneously with sleeping EEG activity in the other hemisphere. Unihemispheric sleep has been recorded in dolphins [150], whales [151], fur seals [152], and birds [9]. Only NREM sleep has been observed in whales and dolphins, whereas in birds and seals REM sleep is present. Of interest is a recent demonstration of decreased orexin bouton density in the cerebral cortex of a porpoise and a whale compared to ten mammalian species [153]. The presence of unihemispheric sleep offers the significant advantages of an ability for part of the brain to sleep during long-distance migration while maintaining sentinel functions in monitoring the environment [148, 154].
Unihemispheric sleep is clearly an unusual form of physiological sleep. However, there are recent human electrophysiological studies utilizing scalp, intracerebral EEG, and unit recordings which suggest the possibility that there are also coexisting regional differences in human sleep and waking. For example, detailed sleep electrophysiological studies have demonstrated that 85 and 75.8 % of sleep spindles and slow waves, respectively, have been detected in less than half of brain recording sites [155]. This regionality of sleep waveforms, along with the demonstration of unihemispheric sleep in animals, suggests that parasomnias such as sleep walking or RBD may be a manifestation of simultaneously occurring waking and sleep processes. There is also further evidence from intracerebral recordings that motor cortex activation lasting from 5 to more than 60 s can occur simultaneously with an increase in slow wave activity in the dorsolateral prefrontal cortex [156]. Also relevant in this regard is the finding that human sleep spindles recorded in the hippocampus precede the sleep spindles and K complexes characteristic of Stage 2 sleep recorded from neocortical scalp electrodes [157]. Similarly in cats, increases in ventral hippocampus spikes precede the onset of NREM sleep, also suggesting that sleep processes may begin in different brain regions at different times in both animals and humans, strengthening the similarities between these electrophysiological processes [25]. Studies in both the echidna, a primitive egg laying mammal considered the basal stock of living mammals, and the ostrich, a basal bird, demonstrate that elements of both NREM and REM sleep may be simultaneously present during behavioral sleep [158, 159]. Further illustrating the simultaneous presence of different physiological states in humans are data from a single subject with stereotaxically implanted electrodes who experienced confusional nocturnal arousals [160]. During these episodes, there was localized activation of the motor, cingulate, insular, temporopolar, and amygdalar cortices in the presence of slow waves recorded from the frontal and parietal dorsolateral cortices and in the presence of spindles recorded from the hippocampal cortex.
Parasomnias are very poorly understood, and the triggers which initiate waking-like behaviors during sleep are completely unknown. There are no readily available animal preparations in which to study these unusual behaviors. Unihemispheric sleep in marine-dwelling mammals and birds hints that there is a capacity for simultaneous expression of both waking and sleeping electrophysiology in the same brain. However, the mechanisms controlling the expression of unihemispheric sleep may be controlled by different, more orderly processes than the processes which result in the often explosive behavior and vocalizations which accompany many of the human parasomnias. Nonetheless, the parasomnias suggest that sleep and waking may be the manifestation of simultaneous waking and sleep.
Conclusions
Although the behavioral and electrophysiological parameters of sleep have been described in great detail in many living organisms, the cellular origins of sleep are still elusive. Studying living organisms is unlikely to provide a definitive answer to the question of how sleep originated, and the behavioral or cellular origins of sleep cannot be preserved in the fossil record. There is one speculative observation that a dinosaur fossil from the Cretaceous era (between 145 and 65.5 million years ago) has been preserved in an avian-like sleeping posture [161]. Sleep is undoubtedly an ancient behavior which has been conserved through evolution, but the crucial life sustaining functions it serves to maintain its presence in many different species is unclear.
Knowledge about sleep mechanisms has rapidly evolved by utilizing model organisms as the genetic and molecular substrates for the study of mechanisms controlling sleep. Even though there are tremendous benefits to the utilization of these organisms, there are also a number of issues which are raised.
Considerations in the Use of Model Organisms
A major question is whether model organisms can truly serve as models for the exploration of human sleep mechanisms and sleep disorders. As we have seen, there is a remarkable correspondence among the genetic, neurochemical, and cellular operations of model organisms and humans. However, it is obvious that the complexity of human behavior and the unexplored cellular effects of human emotions and psychology upon sleep cannot be unraveled by model organisms. The clinical understanding of human sleep disorders relies not only upon the patient’s descriptions and environment, but also on observations of witnesses to the patient’s symptoms. For example, can it be assumed that frequent movements of the fruit fly’s legs are a model for the uncomfortable sensations described by patients in restless legs syndrome? Thus, even though a model may produce a wealth of information about the “technical” aspects of sleep, this does not ensure that this model is necessarily the model for human discovery. Is human NREM sleep the homologue of behavioral sleep in model organisms? There have been no convincing data which have demonstrated the presence of REM sleep in model organisms, and electrophysiological correlates of human NREM sleep have not been described. This absence of some electrophysiological sleep correlate of behavior is a significant drawback for an organism modeling human sleep. Also, there have been a large number of studies, particularly in drosophila, to suggest that short sleep has adverse effects upon life span. What is the translation factor between old age in “drosophila days” and “human years?” What is the translation factor between short or long drosophila “sleep minutes” and short or long human “sleep hours?” These questions are probably unanswerable. Finally, there are some aspects of sleep in model organisms which are different from human sleep characteristics such as the absence of a homeostatic rebound in sleep following deprivation of quiescence in some mutant flies or the suppression of sleep upon exposure to light and the lack of a subsequent homeostatic response in zebrafish.
These questions should not, of course, discourage the use of model organisms in discovering clues to the cellular and genetic mechanisms of human sleep. There has been a massive increase in understanding the cellular basis of sleep, almost completely unknown just a few years ago, as the result of complex cellular manipulations performed in these organisms. It seems unlikely that model organisms will provide us with a “true” model of sleep disorders such as sleep apnea or narcolepsy, and their major utility may lie in being model organisms for understanding the cellular and genetic basis of sleep.
Besides enlightening our understanding of the cellular mechanisms controlling sleep, another area of interest with respect to the use of model organisms is the demonstration of positive and negative effects of social isolation or enrichment upon sleep. These findings suggest that greater attention should be devoted to exploring the impact of environmental factors in assessing human sleep problems. Furthermore, it would be of interest in these studies to determine in model organisms the effects of, for example, predation or threat on sleep in a controlled environment.
Treatments for Human Sleep Disorders Resulting from the Use of Model Organisms
Ideally, understanding the genetic and cellular mechanisms controlling human sleep would be fruitful in yielding more effective treatments for human sleep problems. There has been one recent addition to the armamentarium of sleeping medications, suvorexant, which was developed directly as the result of research in narcolepsy and the identification of orexigenic neurons in the expression of waking and sleep. The identification of salivary amylase as a marker for sleepiness which arose from cross-translational studies in drosophila and humans may also potentially find a practical use in the more widespread identification of sleepiness. With continued research into the details of sleep mechanisms revealed by the use of model organisms, it is anticipated that these findings will translate into practical applications.
Phylogenetic Studies and Human Sleep
The remarkable diversity in sleep behavior and electrophysiology in nonmammalian organisms has provided an array of clues which sheds light upon the understanding of normal and disturbed human sleep. One of the most interesting examples of diversity in animal sleep is the unihemispheric sleep of cetaceans which challenges the notion that sleep is a global state affecting all areas of the brain in the same manner and at the same time. Organisms which display unusual sleep-related behavior such as sleep swimming fish, cetaceans, and their offspring which do not exhibit behavioral sleep for several continuous months after birth, and the demonstration of prolonged, continuous flight in birds offer hints that there may be clues in nature for at least some human sleep complaints of short sleep. New monitoring techniques such as high-resolution video monitoring, in vivo calcium imaging, and multielectrode recording probes hold promise for more refined analyses of behavior and electrophysiology in nonmammalian species [110, 162, 163]. Additionally, behavioral and electrophysiological studies of animals in their own habitats utilizing new technologies will expand our understanding of the diversity of sleep.
Sleep studies in animals have unquestionably enhanced our appreciation of the behavioral, molecular, and environmental factors which govern the expression of sleep, and, in turn, these studies have provided insight into the factors influencing human sleep and its disorders. The biological symphony of sleep continues to be performed throughout nature, and ongoing scientific exploration on a variety of fronts will only continue to enlighten our understanding of this intricate, universal composition.
References
Toth LA, Bhargova P (2013) Animal models of sleep disorders. Comp Med 63:91–104
Allada R, Siegel J (2008) Unearthing the phylogenetic roots of sleep. Curr Biol 18:R670–R678
Hartse KM (2011) The phylogeny of sleep. In: Montagna P, Chokroverty S (vol eds) Handbook of clinical neurology, vol 98, 3rd series. Sleep disorders part I. Elsevier B.V., New York, pp 97–109
Libourel P-A, Herrel A (2015) Sleep in amphibians and reptiles: a review and a preliminary analysis of evolutionary patterns. Biol Rev. doi:10.1111/brv.12197 [E pub ahead of print] PMID 26031314
McNamara P, Barton RA, Nunn CL (eds) (2010) Evolution of sleep. Phylogenetic and functional perspectives. Cambridge University Press, New York
Tobler I (2011) Phylogeny of sleep regulation. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine, 5th edn. Elsevier Saunders, St. Louis, pp 112–125
Berry RB, Brooks R, Gamaldo CE, Harding SM, Lloyd RM, Marcus CL, Vaughn BV for the American Academy of Sleep Medicine (2015) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, version 2.2. American Academy of Sleep Medicine, Darien, Illinois. www.aasmnet.org
Rechtschaffen A, Kales A (eds) (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. BIS/BRI, Los Angeles
Rattenborg NC, Amlaner CJ (2010) A bird’s eye view of the function of sleep. In: McNamara P, Barton RA, Nunn CL (2010) Evolution of sleep. Phylogenetic and functional perspectives. Cambridge University press, New York, pp 145–171
Nitz DA, Van Swinderen B, Tonono G, Greenspan RJ (2002) Electrophysiological correlates of rest and activity in Drosophila melanogaster. Curr Biol 12:1934–1940
Van Alphen B, Yap MHW, Kirszenblat L, Kottler B, van Swindern B (2013) A dynamic deep sleep stage in Drosophila. J Neurosci 33:6917–6927
Fang G, Chen Q, Cui J, Tang Y (2012) Electroencephalogram bands modulated by vigilance states in an anuran species: a factor analysis approach. J Comp Physiol A 198:119–127
Brown ER, Piscopo S, DeStefano R, Gioditta A (2006) Brain and behavioural evidence for rest-activity cycles in Octopus vulgaris. Behav Brain Res 172:335–339
Mendoza-Angeles K, Hernandez-Falcon J, Ramon F (2010) Slow waves during sleep in crayfish. Origin and spread. J Exp Biol 213:2154–2164
Flanigan WF (1973) Sleep and wakefulness in iguanid lizards, Ctenosaura pectinata and Iguana iguana. Brain Behav Evol 8:401–436
Flanigan WF (1974) Sleep and wakefulness in chelonian reptiles. II. The red-footed tortoise, Geochelone carbonaria. Arch Ital Biol 112:253–277
Flanigan WF, Wilcox RH, Rechtschaffen A (1973) The EEG and behavioral continuum of the crocodilian, Caiman sclerops. Electroencephalogr Clin Neurophysiol 34:521–538
Flanigan WF, Knight CP, Hartse KM, Rechtschaffen A (1974) Sleep and wakefulness in chelonian reptiles. I. The box turtle, Terrapene carolina. Arch Ital Biol 112:227–252
Rattenborg NC, Lesko JA, Martinez-Gonzalez D, Lima SL (2007) The nontrivial functions of sleep. Sleep Med Rev 11:405–409
Rial RV, Nicolau MC, Gamund A, Akaarir M, Aparicio S, Garau C et al (2007a) The trivial function of sleep. Sleep Med Rev 11:311–325
Rial RV, Nicolau MC, Gamund A, Akaarir M, Aparicio S, Garau C et al (2007b) Sleep and wakefulness, trivial and nontrivial: which is which? Sleep Med Rev 11:411–417
Warner BF, Huggins SE (1978) An electroencephalographic study of sleep in young caimans in a colony. Comp Biochem Physiol 59A:139–144
Ayala-Guerrero F, Mexicano G (2008) Sleep and wakefulness in the green iguanid lizard (Iguana iguana). Comp Biochem Physiol A Mol Integr Physiol 151:305–312
DeVera L, Gonzalez J, Rial RV (1994) Reptilian waking EEG: slow waves, spindles and evoked potentials. Electroencephalogr Clin Neurophysiol 90:298–303
Hartse KM, Eisenhart SF, Bergmann BM, Rechtschaffen A (1979) Hippocampal spikes during sleep, wakefulness, and arousal in the cat. Sleep 1:231–246
Azevedo FAC, Carvalho RB, Grinberg LT, Farfel JM, Ferreh REL, Leite REP et al (2009) Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J Comp Neurol 515:532–541
Ito M, Masuda N, Shinomiya K, Endo K, Ito K (2013) Systematic analysis of neural projections reveals clonal composition of the Drosophila brain. Curr Biol 23:644–665
Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M, Collins JE et al (2013) The zebrafish reference genome sequence and its relationship to the human genome. Nature 496:498–503
Hillier LW, Coulson A, Murray JI, Bao Z, Sulston JE, Waterston RH (2005) Genomics in C. elegans: so many genes such a little worm. Genome Res 15:1651–1660
Reiter LT, Potocki L, Chien S, Gribskov M, Bier E (2013) A systematic analysis of human disease associated gene sequences in Drosophila melanogaster. Genome Res 11:1114–1125
Rubin GM, Yandell MD, Wortman JR, Gabor Miklos GL, Nelson CR, Hariharan IK et al (2000) Comparative genomics of the eukaryotes. Science 287:2204–2215
Crocker A, Sehgal A (2008) Octopamine regulates sleep in drosophila through protein kinase A-dependent mechanisms. J Neurosci 28:9377–9385
Nichols CD (2006) Drosophila melanogaster neurobiology, neuropharmacology, and how the fly can inform central nervous system drug discovery. Pharmacol Ther 112:677–700
Hendricks JC, Finn SM, Panckeri KA, Chavkin J, Williams JA, Sehgal A, Pack AI (2000) Rest in Drosophila is a sleep-like state. Neuron 25:129–138
Shaw PJ, Cirelli C, Greenspan RJ, Tononi G (2000) Correlates of sleep and waking in Drosophila melanogaster. Science 287:1834–1837
Andretic R, Van Swindern B, Greenspan RJ (2005) Dopaminergic modulation of arousal in drosophila. Curr Biol 15:1165–1175
Hendricks JC, Kirk D, Panckeri KA, Miller MS, Pack AI (2003) Modafinil maintains waking in the fruit fly Drosophila melanogaster. Sleep 26:139–146
Seugnet L, Boera J, Gottschalk L, Duntley S, Shaw PJ (2006) Identification of a biomarker for sleep drive in flies and humans. PNAS 103:19913–19918
Koh K, Evans JM, Hendricks JC, Sehgal A (2006) A Drosophila model for age-associated changes in sleep-wake cycles. Proc Nat Acad Sci 103:13843–13847
Kalueff AV, Stewart AM, Gerlai R (2014) Zebrafish as an emerging model for studying complex brain disorders. Trends Pharmacol Sci 35:63–75
Zhdanova IV (2011) Sleep and its regulation in zebrafish. Rev Neurosci 22:27–36
Belfer SJ, Chuang H-S, Freeman BJ, Yuan J, Norton M, Bau HH, Raizen DM (2013) Caenorhabditis-in-drop array for monitoring C. elegans quiescent behavior. Sleep 36:689–698
Raizen D, Zimmerman JE, Maycock MH, Ta UD, You Y-J, Surdaram MV et al (2008) Lethargus is a Caenorhabditis elegans sleep-like state. Nature 451:569–572
Iwanir S, Tramm N, Nagy S, Wright C, Ish D, Biron D (2013) The microarchitecture of C. elegans behavior during lethargus: homeostatic bout dynamics, a typical body posture, and regulation by a central neuron. Sleep 36:385–395
Singh K, Ju JY, Walsh MB, Dilorio MA, Hart PC (2014) Deep conservation of genes required for both Drosophila melanogaster and Caenorhabditis elegans sleep includes a role for dopaminergic signaling. Sleep 37:1439–1451
MacWilliam D, Arensburger P, Higa J, Cui X, Adams ME (2015) Behavioral and genomic characterization of molt-sleep in the tobacco hornworm, Manduca sexta. Insect Biochem Mol Biol 62:154–167
Hammond W (1866) Wakefulness. J B Lippincott and Company, Philadelphia, p 42
Parthasarathy S, Vasquez MM, Halonen M, Bootzin R, Quan SF, Martinez FD et al (2015) Persistent insomnia is associated with mortality risk. Am J Med 128:268–275
Leng Y, Cappuccio FP, Wainwright NWJ, Surtees PG, Luben R, Brayje C, Khow K-T (2015) Sleep duration and risk of fatal and nonfatal stroke. Neurology 84:1–8
Kripke DF, Simons RN, Garfinkel L, Hammond C (1979) Short and long sleeping pills. Is increased mortality associated? Arch Gen Psychiatry 36:103–116
Buxton OM, Marcelli E (2010) Short and long sleep are positively associated with obesity, diabetes, hypertension, and cardiovascular disease among adults in the United States. Social Sci Med 71:1027–1036
Hall MH, Smagula SF, Boudreau RM, Ayondyon HN, Goldman SE, Harris TB et al (2015) Association between sleep duration and mortality is mediated by markers of inflammation and health in older adults: the health. Aging and body composition study. Sleep 38:189–195
Cappuccio FP, D’Ela L, Strazzullo P, Miller MA (2010) Sleep duration and all cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 33:585–592
Grandner MA, Drummond SPA (2007) Who are the long sleepers? Towards an understanding of the mortality relationship. Sleep Med Rev 11:341–360
Grandner MA, Hale L, Moore M, Patel NP (2010) Mortality associated with short sleep duration: the evidence, the possible mechanisms, and the future. Sleep Med Rev 14:191–203
Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR (2002) Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 59:131–136
Watson NF, Badr MS, Belenky G, Bliwise DL, Buxton OM, Buysse D, Dinges DF, Gangwisch J, Grandner MA, Kushida C, Malhotra RK, Martin JL, Patel SR, Quan SF, Tasali E (2015) Joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society on the recommended amount of sleep for a healthy adult: methodology and discussion. Sleep 38:1161–1183
Kurina LM, McClintock MK, Chen J-H, Waite LJ, Thisted RA, Lauderdale DS (2013) Sleep duration and all-cause mortality: a critical review of measurement and associations. Ann Epidemol 23:361–370
Kripke DF, Langer RD, Kline LE (2012) Hypnotic association with mortality or cancer: a matched cohort study. BMJ Open 2:e00850
Cirelli C, Bushey D, Hill S, Huber R, Kreber R, Ganetzky B, Tonono G (2005) Reduced sleep in Drosophila Shaker mutants. Nature 434:1087–1092
Koh K, Joiner WJ, Wu MN, Yue Z, Smith CJ, Sehgal A (2008) Identification of SLEEPLESS, a sleep-promoting factor. Science 321:372–376
Stavropoulos N, Young MW (2011) Insomniac and Cullin-3 regulate sleep and wakefulness in Drosophila. Neuron 72:964–976
Kume K, Kume S, Park SK, Hirsh J, Jackson FR (2005) Dopamine is a regulator of arousal in the fruit fly. J Neurosci 25:7377–7384
Ueno T, Tomita J, Tanimoto H, Endo K, Ito K, Kume S et al (2012) Identification of a dopamine pathway that regulates sleep and arousal in Drosophila. Nat Neurosci 15:1516–1524
Liu W, Guo F, Lu B, Guo A (2008) “Amnesiac” regulates sleep onset and maintenance in Drosophila melanogaster. Biochem Biophys Res Commun 372:798–803
Yamazaki M, Tomita J, Takahama K, Ueno T, Mitsuyoshi M, Sakamoto E, Kume S, Kume K (2012) High calorie diet augments age-associated sleep impairment in Drosophila. Biochem Biophy Res Commun 417:812–816
Gill S, Le HD, Melkani GC, Panda D (2015) Time restricted feeding attenuates age related cardiac decline in Drosophila. Science 347:1265–1269
Bushey D, Tononi G, Cirelli C (2009) The Drosophila Fragile X mental retardation gene regulates sleep need. J Neurosci 7:1948–1961
Rogulja D, Young MW (2012) Control of sleep by cyclin A and its regulator. Science 335:1617–1621
Shi M, Yue Z, Kuryatov A, Lindstrom JM, Sehgal A (2014) Identification of redeye, a new sleep-regulating protein whose expression is modulated by sleep amount. eLife 3:e01473. doi:10.7554/eLife.01473
Roth T (2007) Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med 3(5 Suppl):S7–S10
Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM et al (2001) An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 291:1040–1043
Lugaresi E, Medori R, Montagna P, Baruzzi A, Cortelli P, Lugaresi A, Tinuper P, Zucconi M, Gambetti P (1986) Fatal familial insomnia and dysautonomia with selective degeneration of the thalamic nuclei. NEJ Med 315:997–1003
Cortelli P, Gambetti PL, Montagna P, Lugaresi E (1999) Fatal familial insomnia. Clinical features and molecular genetics. J Sleep Res 8(Suppl 1):23–29
He Y, Jones CR, Fujiki N, Xu Y, Guo B, Holder JL, Rossner MJ, Nishino S, Fu Y-H (2009) The transcriptional repressor DEC2 regulates sleep length in mammals. Science 325:866–870
Pellegrino R, Kavakli IH, Goel N, Cardinale CJ, Dinges DF, Kuna ST, Maislin G, Van Dongen HPA, Tufik S, Hogenesch JB, Hakonarson H, Pack AI (2014) A novel BHLHE41 variant is associated with short sleep and resistance to sleep deprivation in humans. Sleep 37:1327–1336
Donlea JM, Ramanan N, Silverman N, Shaw PJ (2014) Genetic rescue of functional senescence in synaptic and behavioral plasticity. Sleep 37:1427–1437
Linford NJ, Bilgir C, Ro J, Pletcher SD (2013) Measurement of lifespan in Drosophila melanogaster. J Vis Exp 71:e50068
Koudounas S, Green EW, Clancy D (2012) Reliability and variability of sleep and activity as biomarkers of ageing in Drosophila. Biogerontology 13:489–499
Svetec N, Zhao L, Saelao P, Chiu JC, Begun DJ (2015) Evidence that natural selection maintains genetic variation for sleep in Drosophila melanogaster. BMC Evol Biol 15:41. doi:10.1186/s12862-015-0316-2
Zimmerman JE, Raizen DM, Maycock MH, Maislin G, Pack AI (2008) A video method to study Drosophila sleep. Sleep 31:587–598
Zimmerman JE, Chan MT, Jackson N, Maislin G, Pack AI (2012) Genetic background has a major impact on differences in sleep resulting from environmental influences in Drosophila. Sleep 35:545–557
Chi MW, Griffith LC, Vecsey (2014) Larval population density alters adult sleep in wild-type Drosophila melanogaster but not in Amnesiac mutant flies. Brain Sci 4:453–470
Eban-Rothschild A, Bloch G (2015) The colony environment modulates sleep in honey bee workers. J Exp Biol 218(Pt 3):404–411
Rattenborg NC, Voirin B, Vyssotski AL, Kays RW, Spoelstra K, Vemmeth W et al (2008) Sleeping outside the box: electroencephalographic measures of sleep in sloths inhabiting a rainforest. Biol Lett 4:402–405
Allison T, Cicchetti D (1976) Sleep in mammals: ecological and constitutional correlates. Science 194:732–734
Lima SL, Rattenborg NC, Lesku JA, Amlander CJ (2005) Sleep under risk of predation. Anim Behav 70:723–736
Noser R, Gygax L, Tobler I (2003) Sleep and social statu in captive gelada baboons (Theropithecus gelada). Behav Brain Res 147:9–15
Duboue ER, Keene AC, Borowsky RL (2011) Evolutionary convergence on sleep loss in cavefish populations. Curr Biol 21:671–676
Duboue ER, Borowsky RL, Keene AC (2012) B-adrenergic signaling regulates evolutionarily derived sleep loss in the Mexican cavefish. Brain Behav Evol 80:233–243
Lucas-Sanchez A, Almaida-Pagan PF, Martinez-Nichols A, Madrid JA, Mendiola P, de Costa J (2013) Rest-activity circadian rhythms in aged Nothobranchius korthausae. The effects of melatonin. Exp Gerontol 48:507–516
Hur S-P, Takeuchi Y, Itoh H, Uchimura M, Takahashi K, Kang H-C, Lee Y-D, Kim S-J, Takemura A (2012) Fish sleeping under sandy bottom: interplay of melatonin and clock genes. Gen Comp Endocrinol 37–45:37–45
Santoriello C, Zon LI (2012) Hooked! Modeling human disease in zebrafish. J Clin Invest 122:2337–2343
Thimgan MS, Gottschalk L, Toedebusch C, McLeland J, Rechtschaffen A, Gilliland-Roberts M, Duntley SP, Shaw PJ (2013) Cross-translational studies in human and Drosophila identify markers of sleep loss. PLoS ONE 8:e61016. doi:10.1371/journal.pone.0061016
Standards of Practice Committee of the American Academy of Sleep Medicine (2005) Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 28:113–121
Dement WC (1999) The promise of sleep. Delacort Press Random House, New York
De la Herran-Arita AK, Guerra-Crespo M, Drucker-Colin R (2011) Narcolepsy and orexins: an example of progress in sleep research. Front Neurol 2:1–8
Faraco J, Mignot E (2011) Immunological and genetic aspects of narcolepsy. Sleep Med Res 2:2–9
Longstreth WT, Koepsell TD, Ton TGB, Hendrickson AT, Van Belle G (2007) The epidemiology of narcolepsy. Sleep 30:13–26
Shaw P, Tafti M, Thorpy M (eds) (2013) The genetic basis of sleep and its disorders. Cambridge University Press, New York
Mahlios J, De la Herran-Arita AK, Mignot E (2013) The autoimmune basis of narcolepsy. Curr Opin Neurobiol 23:767–773
Dauvilliers Y, Montplaisir J, Cochen V, Desautels A, Einen M, Lin I et al (2010) Post-H1N1 narcolepsy-cataplexy. Sleep 33:1428–1430
Koepsell TD, Longstreth WT, Ton TG (2010) Medical exposures in youth and the frequency of narcolepsy with cataplexy: a population-based case-control study in genetically predisposed people. J Sleep Res 19:80–86
Ginn SL, Alexander IE, Edelstein ML, Abedi MR, Wion J (2013) Gene therapy clinical trials worldwide to 2012—an update. J Gene Med 15:65–77
Kantor S, Mochizuki T, Lops SN, Ko B, Clain E, Clark E, Yamamoto M, Scammell TE (2013) Orexin gene therapy restores the timing and maintenance of wakefulness in narcoleptic mice. Sleep 36:1129–1138
Liu M, Blanco Centuron C, Konadhode RR, Begum S, Pelluru D, Gerashchenko D, Sakurai T, Yanagisawa M, van den Pol AN, Shiromani PJ (2011) Orexin gene transfer into zona incerta neurons suppresses muscle paralysis in narcoleptic mice. J Neurosci 31:6028–6040
Herring WJ, Connor KM, Ivgy-May N, Snyder E, Liu K, Snavely DB, Krystal AD, Walsh JK, Benca RM, Rosenberg R, Sangal RB, Budd K, Hutzelmann J, Leibensperger H, Froman S, Lines C, Roth T, Michelson D (2014) Suvorexant in patients with insomnia: results from two 3-month randomized controlled clinical trials. Biol Psychiatry. pii: S0006-3223(14)00762-8. doi:10.1016/j.biopsych.2014.10.003. [Epub ahead of print]
Sun H, Kennedy WP, Wilbraham D, Lewis N, Calder N, Li X, Ma J, Yee KL, Ermlich S, Mangin E, Lines C, Rosen L, Chodakewitz J, Murphy HM (2013) Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men. Sleep 36:259–267
Parker I (2013) The big sleep. The New Yorker, pp 50–63
Arnason BB, Porsteinsson H, Karlsson KE (2015) Absence of rapid eye movements during sleep in adult zebrafish. Behav Brain Res 291:189–194
Prober DA, Rihel J, Onah AA, Sung R-J, Schier AF (2006) Hypocretin/orexin overexpression induces an insomnia-like phenotype in zebrafish. J Neurosci 26:13400–13410
Yokogawa T, Marin W, Faraco J, Pezeron G, Appelbaum L, Zhang J, Rose F, Mourrain P, Mignot E (2007) Characterization of sleep in zebrafish and insomnia in hypocretin receptor mutants. PLoS Biol 5:e277. doi:10.137l/journal.pbio.0050277
Dumitrascu R, Heitmann J, Seeger W, Weissmann N, Schulz R (2013) Obstructive sleep apnea, oxidative stress and cardiovascular disease: lessons from animal studies. Oxid Med Cell Longevity 234631
Louis JM, Mogos MF, Salemi JL, Redline S, Salihu HM (2014) Obstructive sleep apnea and severe maternal-infant morbidity/mortality in the United States, 1998–2009. Sleep 37:843–849
Ovchinsky A, Rao M, Lotwin I, Goldstein NA (2002) The familial aggregation of pediatric obstructive sleep apnea syndrome. Arch Otolaryngol Head Neck Surg 128:815–818
Redline S, Tosteson T, Tishler PV, Carskadon MA, Millman RP (1992) Familial aggregation of symptoms associated with sleep related breathing disorders. Am Rev Respir Dis 145:440–444
Strohl KP, Saunders NA, Feldman NT, Halett M (1978) Obstructive sleep apnea in family members. N Engl J Med 299:969–973
Hendricks JC, Kline LR, Kovalski JA, O’Brien JA, Morrison AR, Pack AI (1987) The English bulldog: a natural model of sleep-disordered breathing. J Appl Physiol 63:1344–1350
Lonergan RP, Ware JC, Atkinson RL, Winter WC, Suratt PM (1998) Sleep apnea in obese miniature pigs. J Appl Physiol 84:531–536
Farre R, Nacher M, Serrano-Mollar A, Galdiz JB, Alvarez FJ, Navajas D, Montserrat JM (2007) Rat model of chronic recurrent airway obstructions to study the sleep apnea syndrome. Sleep 30:930–933
Kimoff RJ, Makino H, Horner RL, Kozar LF, Lue F, Slutsky AS, Phillipson EA (1994) Canine model of obstructive sleep apnea: model description and preliminary application. J Appl Physiol 76:1810–1817
Kimoff RJ, Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Champagne V, Mayer P, Phillipson EA (1997) Ventilatory and arousal responses to hypoxia and hypercapnia in a canine model of obstructive sleep apnea. Am J Respir Crit Care Med 156:886–894
Simpson JA, Brunt KR, Iscoes S (2008) Repeated inspiratory occlusion acutely impairs myocardial function in rats. J Physiol 586:2345–2355
Thakret P, Mamtani MR, Kulkami A (2009) Lack of association of the APOEe4 allele with the risk of obstructive sleep apnea: meta-analysis and meta-regression. Sleep 32:1507–1511
Varvarigou V, Dahabreh IJ, Malhotra A, Kales SN (2011) A review of genetic association studies of obstructive sleep apnea: field synopsis and meta analysis. Sleep 34:1461–1468
Auora RN, Kristo DA, Bista SR, Rowley JA, Zak RS, Casey KR, Lamm CI, Tracy SI, Rosenberg RS (2012) The treatment of restless legs syndrome and periodic limb movement disorder in adults—An update for 2012: practice parameters with an evidence-based systematic review and meta-analyses. Sleep 35:1039–1062
Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4:101–119
Ohayon MM (2012) Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev 16:283–295
Kemlink D, Polo O, Frauscher B, Gschliesser V, Hogl B, Poewe W, Vodicka P, Vavrova J, Sonka K, Nevimalova S, Schormair B, Lichtner P, Silander K, Peltonen L, Gieger C, Wichmann HE, Zimprich A, Roeske D, Muller-Myhsok B, Meitinger T, Winelmann J (2009) Replication of restless legs syndrome loci in three European populations. J Med Genet 46:315–318
Winkelmann J, Schormair B, Lichtner P, Ripke S, Xiong L, Jalilzadeh S, Fulda S, Putz B, Eckstein G, Hauk S, Trenkwalder C, Zimprich A, Stiasny-Kolster K, Oertel W, Bachmann CG, Paulus W, Peglau I, Eisensehr I, Montplaisir J, Turecki G, Rouleau G, Gieger C, Illig T, Wichman HE, Holsboer F, Muller-Myhsok B, Meitinger T (2007) Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 39:1000–1006
Yang Q, Li L, Chen Q, Foldvary-Schaefer N, Ondo WG, Wang QK (2011) Association studies of variants in MES1, BTBD9, and MAP2K5/SKOR1 with restless legs syndrome in a US population. Sleep Med 12:800–804
Qu S, Le W, Zhang X, Xie W, Zhang A, Ondo WG (2007) Locomotion is increased in A11-lesioned mice with iron deprivation: a possible animal model for restless legs syndrome. J Neuropathol Exp Neurol 66:383–388
Lopes C, Esteves AM, Frussa-Filho R, Tufik S, de Mello MT (2012) Evaluation of periodic limb movements in a putative animal model of restless leg syndrome. Mov Disord 27(3):413–420
Esteves A, Lopes C, Frussa-Filho R, Frank MK, Cavagnolli D, Arida RM et al (2013) Spontaneously hypertensive rats: possible animal model of sleep-related movement disorders. J Mot Behav 45:487–493
Catoire H, Dion PA, Xiong L, Aman M, Gaudet R, Girard SL, Noreau A, Gaspar C, Turecki G, Montplaisir J, Parker JA, Rouleau GA (2011) Restless legs syndrome associated MEIS1 risk variant influences iron homeostasis. Ann Neurol 70:170–175
Freeman A, Pranak E, Miller RD, Radmard S, Bernhard D, Jinnah H et al (2012) Sleep fragmentation and motor restlessness in a Drosophila model of restless legs syndrome. Curr Biol 22:1142–1148
Montplaisir J, Boucher S, Nicolas A, Lesperance P, Gosselin A, Rompre P, Lavigne G (1998) Immobilization tests and periodic leg movements in sleep for the diagnosis of restless legs syndrome. Mov Disord 13:324–329
American Academy of Sleep Medicine (2014) International classification of sleep disorders, 3rd edn. American Academy of Sleep Medicine, Darien
Ohayon MM, Mahowald MW, Dauvilliers Y, Krystal AD, Leger D (2012) Prevalence and comorbidity of nocturnal wandering in the US adult general population. Neurology 72:1583–1589
Kang H-H, Yoon I-Y, Lee SD, Han JW, Kim TH, Kim KW (2013) REM sleep behavior disorder in the Korean elderly population: prevalence and clinical characteristics. Sleep 36:1147–1152
Jouvet M, Delorme F (1965) Locus coeruleus et sommeil paradoxical. C R Sances Soc Biol Fil 159:895–899
Schenck CH, Bundlie SR, Ettinger MG, Mahowald M (1986) Chronic behavioral disorders of human REM sleep: a new category of parasomnias. Sleep 9:293–308
Goldschmid R, Holzman R (2004) Aeration of corals by sleep-swimming fish. Limmol Oceanogr 49:1832–1839
Lyamin O, Pryaslova J, Lance V, Siegel J (2005) Continuous activity in cetaceans after birth. Nature 435:1177
Lyamin O, Pryaslova J, Kosenko P, Siegel J (2007) Behavioral aspects of sleep in bottlenose dolphin mothers and their calves. Physiol Behav 92:725–733
Branstetter BK, Finneran JJ, Fletcher EA, Weisman BC, Ridgway SH (2012) Dolphins can maintain vigilant behavior through echolocation for 15 days without interruption or cognitive impairment. PLoS ONE 7:e47478. doi:10.1371/journal.pone.0047478
Liechti F, Witvliet W, Weber R, Bachler E (2013) First evidence of a 200-day non-stop flight in a bird. Nat Commun 4:2554. doi:10.1038/ncomms3554
Rattenborg NC (2006) Do birds sleep in flight? Naturwissenschaften 93:413–425
Rattenborg NC, Mandt BH, Obermyer WH, Winsauer PJ, Huber R, Wikelski M, Benca R (2004) Migratory sleeplessness in the white-crowned sparrow (Zonotrichia leucophrys gambelii). PLoS Biol 2:0924–0936
Mukhametov LM, Supin AY, Polyakova IG (1977) Interhemispheric asymmetry of the electroencephalographic sleep patterns in dolphins. Brain Res 134:581–584
Lyamin OI, Mukhametov LM, Siegel JM, Nazarenko EA, Polyakova IG, Shpak OV (2002) Unihemispheric slow wave sleep and the state of the eyes in a white whale. Behav Brain Res 129:125–129
Lyamin OI, Lapierre JL, Kosenko PO, Mukhametov LM, Siegel JM (2008) Electroencephalogram asymmetry and spectral power during sleep in the northern fur seal. J Sleep Res 17:154–165
Dell L-A, Spocter MA, Patzke N, Karlson KE, Alagaili AN, Bennett NC, Muhammed OB, Bertelsen MF, Siegel JM, Manger PR (2015) Orexinergic bouton density is lower in the cerebral cortex of cetaceans compared to artiodactyls. J Chem Neuroanat 68:61–76
Lyamin O, Manger PR, Ridgway SH, Mukhametov LM, Siegel JM (2008) Cetacean sleep: an unusual form of mammalian sleep. Neurosci Biobehav Rev 32:1451–1484
Nir Y, Staba RJ, Andrillon T, Vyazovskly V, Cirelli C, Fried I, Tononi G (2011) Regional slow waves and spindles in human sleep. Neuron 70:153–169
Nobili L, Ferrara M, Moroni F, DeGennaro L, LoRusso G, Campus C, Cardinale F, DeCarli F (2011) Dissociated wake-like and sleep-like electro-cortical activity during sleep. Neurolimage 58:612–619
Sarasso S, Proserpio P, Pigorini A, Moroni F, Ferrara M, De Gennaro L, De Carli F, Lo Russo G, Massimini M, Nobili L (2014) Hippocampal sleep spindles preceding neocortical sleep onset in humans. Neurolmage 86:425–432
Lesku JA, Meyer LCR, Fuller A, Maloney SK, Dell’Omo G et al (2011) Ostriches sleep like platypuses. PLoS ONE 6(8):e23203. doi:10.1371/journal.pone.0023203
Siegel JM, Manger PR, Niehuis R, Fahringer HM, Shalita T, Pettigrew JD (1999) Sleep in the platypus. Neuroscience 91:391–400
Terzaghi M, Sartori I, Tassi L, Rustioni V, Proserpio P, L’Orusso G, Manni R, Nobili L (2012) Dissociated local arousal states underlying essential clinical features of non-rapid eye movement arousal parasomnias: an intracerebral stereo-electroencephalographic study. J Sleep Res 21:502–506
Xu X, Norell MA (2014) A new troodontid dinosaur from China with avian like sleeping posture. Nature 431:838–841
Beckers G, Van Der Meij J, Lesku JA, Rattenborg NC (2014) Plumes of neuronal activity propagate in three dimensions through the nuclear avian brain. BMC Biol 12:16
Bushey D, Tononi G, Cirelli C (2015) Sleep- and wake-dependent changes in neuronal activity and reactivity demonstrated in fly neurons using in vivo calcium imaging. PNAS 112:4785–4790
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hartse, K.M. (2017). Phylogeny of Sleep. In: Chokroverty, S. (eds) Sleep Disorders Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-6578-6_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6578-6_9
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-6576-2
Online ISBN: 978-1-4939-6578-6
eBook Packages: MedicineMedicine (R0)